American Association of Practitioners and Researchers of Ayurveda

 

 

                 Home

             Membership

                 Committees

             Coursework

             Sources

                 Scope

             Ethics

             Research Institutes

             Hospitals

             Diseases  

             Licensing Petition

             Licensing Justified

             Lectures

             Articles

             Herbs

             Manufacturing

             Ethics

             Newsletter

        

 

    

                                                              AAPRA

Justification for Licensing Ayurvedic Medicine of India (AMI) in the US

Type of License:  AMI practitioners are asking for license only to use Ayurvedic procedures and therapies to diagnose, prevent, and treat diseases and not asking to use allopathic methods and treatments, thus, there is no conflict with MDs.                We are asking the same type of license as given to Acupuncture and Oriental Medicine which allows them initial point of contact physician rights.

1.                                               Medical professional societies supporting regulation of AMI in Maryland

      (1) Am Assoc. of Physicians of Indian Origin  (AAPI) (MDs and AMI degree holders, >45000 members) V. Koli, MD,

         President, H. Sharma, Chair of Integrative medicine committee AAPI 

(2) Assoc. of Ayurvedic Professionals of North America (AAPNA)www.apna.org.

(3) Am. Assoc. of Practitioners, Researchers of Ayurveda  (AAPRA)

(4)  Florida Vedic College

2.  No conflict with conventional medicine:  License will include only the right to use ayurvedic diagnostic methods, diagnosis, prevention, treatment; the license would NOT allow the use of conventional medicine diagnostic methods and treatments.

 

3. Tragic Incidence: AMI practitioners need to have the necessary training and license to practice AMI so that incidences similar to the death of Coretta Scott King (Washington Post, 2 6 06) do not adversely affect AMI practitioners.

 

4. Inadequate Training:  Inadequately trained practitioners undermine the safety of the patients, provide less than optimum treatment, may produce a delay in proper treatment, and jeopardize the growth of the medical system.  AMI is not regulated in any State at this time.

 

5. Regulation of common therapies: Non-conventional therapies regulated in other countries are also regulated in the US.  Ayurveda is not.  Even non-drug therapies like massage and chiropractic are regulated in the US.   Massage therapy license requires 500 to 1000 hours of training, passage of National Board Exams, and other requirements before being allowed to practice in most states.  There is no ingestion of single herbs or formulas in Massage Therapy, but, it is currently regulated where as Ayurveda which includes use of herbals and procedures such as, blood letting, strong purgatives and emetics, requiring significant training is not.

 

6. Regulations: Lack of regulation allows unqualified persons to practice Ayurveda which has the potential for initiating and exacerbating health problems.  Regulation will encourage qualified Ayurvedic physicians to practice in Maryland.

 

7. AMI practitioners:  AMI practitioners whose training is limited to 500 total lecture hour and do not hold a separate medical degree are really not qualified to treat diseases, however, they are often implicitly advised by AMI schools that they can practice AMI as long as they do not use the words like “diagnose, prevent, treat and cure’ in their practice.

8. AMI Training Schools: Currently there are over 20 educational facilities in the US offering AMI training limited to a total of 500 hours which is drastically low in view of the fact that a minimum of 3,560 total hours and one year of internship is required in India for licensing.  These training schools have created thousands of insufficiently trained AMI practitioners.  None of the schools are accredited by regional accreditation boards such as WASC, SASC, etc.

 

9. Scope of AMI training: AMI is similar in scope to conventional medicine and includes similar subjects:  (1).Sharir Rachana (Ayurvedic Anatomy),(2) Sharir Kriya (Ayu.  Physiology),  (3) Kaya chikitsa (Ayu. Medicine), (4). Shalya Chikitsa (Ayu. Minor surgery), (5) Netra Roga (Ayu. Eye), (6) Shalakya Chikitsa, (Ayu. Ear, Nose and Throat), (7) Kaumarbhratya (Ayu. Pediatrics), (8) Prasuti Tantra (Ayu.Obstetrics), (9). Stri Roga  (Ayu. Gynecology), (10) Bhutavidya (Ayu. Psychiatry), 11. Swasthyavrat (Hygiene, mediation, Yoga, life style changes, dietary choices) (11) Agadtantra (Ayu.Toxicology) . 12.) Rasayan Tantra (Ayu.Science of Health and Longevity), (13). Vajeekarantantra (Ayu.Procreative Activity and Rejuvenation), (14). Bhasajya Kalpana (Ayu.Pharmacy), (15) Rasausadhi (Ayu.Drugs of Metals and Mineral origin), (16). Dravya Guna (Ayu.Pharmacology). (17) Padarth Vigyan (Ayu. Physics). 

 

10. Training of AMI also covers the comparative knowledge of similar subjects in conventional medicine.  It covers disease pathology, etiology, diagnosis, prevention, treatment and cure.  In addition AMI has additional seven non-clinical subjects, such as, AMI pathology, AMI  toxicology, and AMI pharmacy and others.

 

11. Hazards from AMI: Many AMI drugs and purification procedures (Panchkarma which includes strong purgatives, emetics and blood-letting) could be hazardous and even fatal if not used under a physician’s supervision. 

 

12. Validity and Scientific Basis of Ayurvedic Therapies: Indian government agencies and universities have studied AMI and published findings in conventional medical journals subscribed by National Library of Medicine and indexed in Index Medicus. Additionally, the NIH, private foundations, and ayurvedic herbal products manufacturers have expended millions of dollars in funds to underpin the safety and effectiveness of AMI therapies.  Many of these findings from the pharmacological, biochemical and clinical studies have been summarized in Scientific Basis of Ayurvedic Therapies, CRC Press Florida, 2003.

 

13.    Popularity of AMI: “Even in such major cities as New Delhi, which boasts several world-class medical facilities, AMI is widely embraced.  Pharmacies stock AMI remedies alongside conventional medical products such as antibiotics” (Washington Post, 1/8/06).

 

14.    Ayurvedic Pharmacopoeia and Formulary of India:  Briefly, AMI has over 1000 therapeutic herbs of which 326 have been included in the Ayurvedic Pharmacopoeia of India, 2004.  In addition, the Ayurvedic Formulary of India has over 780 Text formulas of animal, mineral and plant origin. These books provide specific standards for Ayurvedic herbs and Text formulas.  The Government of India has set up the following permissible limit for heavy metals in Ayurvedic products containing only herbal ingredients for oral administration:  lead, 10 ppm, Cadmium, 0.30 ppm, arsenic 10 ppm, and mercury, 1 ppm.  

 

15.    Usefulness of AMI:  Ayurvedic Text formulas and single herbs are known to be useful in the management of chronic diseases, psychiatric disorders, neurological disorders and maintenance of good health, particularly when patients become resistant to conventional drugs or are unable to utilize conventional drugs due to co-morbidities which put them at risk for side effects from conventional treatment.  Volumes of effectiveness/ efficacy, and safety data have been published both in India as well as the West.

 

16.    Health Care cost:  AMI may bring down the health care cost by providing an alternative therapeutic system.  

1) AMI is known to produces desirable therapeutic effect without causing acute toxic effects, it may save health care costs from the treatment of side effects that may result from conventional drugs.

(2) AMI is not known to cause delayed adverse health effects or secondary diseases which sometimes develop years after the use of a conventional drug, again saving the cost of treating the secondary disorders.

(3) AMI formulas are cited in Texts as useful dietary supplements to improve health, strengthen the cardiovascular system, immune system, improve memory, and relieve depression.  The formulas are cited in Texts to reduce the frequency of illnesses thus may save health care costs. 

(4) AMI therapies and Text formulas are herbal or herbo-mineral formulas and do not have patent rights on them by manufacturers, therefore, they are generally less expensive.

(5) AMI formulas are relatively simpler to make than conventional drugs and does not require chemicals to manufacture.  Since AMI therapies in general are more economic than conventional therapies, their use may also facilitate treatment in rural or economically depressed areas.

17. Supply of AMI Products: With regulation, Ayurvedic suppliers will be encouraged to open outlets in Maryland increasing the tax base while providing local access to high quality Ayurvedic products.

18. Educations:  Education in AMI will be more easily facilitated in states where it is regulated

19.Growth of AMI: No medical system can grow to its full potential without regulation, support and state protection.  Maryland could be on the forefront of the growing interest in Ayurvedic medicine with co-operation among practitioners, users of the medical practice and the government. 

20. Third part payment:  Although, Complimentary Alternative Medicine health services are often not covered by third party payers in a way conventional medicine health services are, however, many CAM therapies (Acupuncture and Oriental Medicine, Chiropractic) are given a certain amount of discount by   health care providers. AMI services are not given such discounts.

21. It is apparent from the scope and extent of AMI that there is a great need for the regulation of AMI in the US so that a minimum standard of education and experience necessary to practice clinical as well as non-clinical aspects of AMI can be enforced to protect public and establish it in the US in a reliable and safe manner.

Post Regulation

Question: How will regulation work since we do not have enough qualified AMI practitioners in the US? 

Response: We have no shortage of qualified AMI practitioners.  We already have 100s of qualified practitioners in the US and another over 368,000 registered qualified AMI practitioners (BAMS) in India and many of them may be interested in coming to the US if they can get license to practice.  Right now, many qualified AMI  practitioners are leaving the US because they can not get license to practice.  These people will form the back bone of the infrastructure of AMI in the US.  After regulation of AMI, training schools will be started.  Training access will follow a path similar to that experienced with the growth of Acupuncture and Oriental Medicine (AOM) back in 1973 when it was first regulated in Massachusetts, USA.  Qualified practitioners with a degree in AOM came to the US and were given licenses in the States where it was regulated.   Slowly, other states regulated AOM and these qualified practitioners provided the infrastructure.  Currently AOM is regulated in 44 states. 

Lakshmi C. Mishra, B. Pharm., M. Pharm., Ph.D., BAMS

President, AAPRA

Betsy B. Singh, Ph.D.                            Mr. Onkar Sharma, Legislative Director

Vice President, AAPRA                          Sharma Law Group

 

 

 


 

 

American Association of Practitioners and Researchers of Ayurveda


Copyright © [2002] [AARPA.COM ]